Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021

  • ID: 3771361
  • Report
  • Region: Global
  • 168 Pages
  • Axis Research Mind
1 of 5
The Highest Insulin Delivery Device CAGR of 9.2% is Anticipated from the Asia-Pacific Region, Middle East Follows with 8.6%, While Africa Forecasts 8.6% Between 2014-2021


  • Abbott Laboratories
  • Ambisea Technology
  • B. Braun Melsungen AG
  • Htl-Strefa S.A
  • Johnson & Johnson
  • Novo Nordisk
  • MORE
Global Market Watch:

The Invasive Devices market is expected to reach US$10.4 billion by 2016 primarily supported by the segments Syringes, Pens, Pumps and Other. Globally, Syringes and Pumps together account for approximately more than 50% of the market and is expected that Insulin Delivery Devices industry to be going forward. Geographical analysis for Invasive Devices market shows that the highest Compounded Annual Growth Rate (CAGR) of 9.2% is anticipated from Asia-Pacific region during the analysis period, 2014-2021. Middle East follows Asia-Pacific with a CAGR of 8.6% while Africa forecasts to drive with a growth rate of 8.6%. As for Non-Invasive Devices the market is increasing at a Compound Annual Growth rate of 10.5% during the analysis period of 2014-2021.

Report Focus:

The report “Insulin Delivery Devices - Global Trends, Estimates and Forecasts, 2014-2021” reviews the latest insulin market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

- Emerging market trends
- Advancements in the technological space
- Market demand of the segments (by-region)
- Key growth areas and market size
- Key competitor’s Edge

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with insulin delivery devices market segment. Further, the subdivided categories include:

Insulin Delivery Devices:

1. Invasive Devices
- a. Syringes
- b. Pens
-- i. Reusable Cartridges
-- ii. Disposable Cartridges
- c. Pumps
- d. Other*

2. Non-Invasive Devices
- a. Inhalers
- b. Patches
- c. Sprays
- d. Jet Injectors

* Other: Softaware of Pumps, Smart Caps, Walet, Syringer Holders, Spring-Loaded Syringe Holders, Syringe Magnifiers and Light, Pen Needles

The period considered for the insulin delivery devices market analysis is 2014-2021. The region wise distribution of the market consists of The Americas (USA, Brazil, Canada, Mexico, Argentina and Rest of The Americas), Europe (Germany, United Kingdom, France, Russia, Italy, Spain, The Netherlands and Rest of Europe), Asia- Pacific (China, Japan, India, South Korea, Australia and Rest of Asia-Pacific), Africa (South Africa, Nigeria, Kenya and Rest of Africa) and Middle East (Egypt, Turkey, UAE and Rest of Middle East). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 40 leading market players are identified and 20 key companies that project improved market activities in the near future are profiled. The report consists of 95 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
Note: Product cover images may vary from those shown
2 of 5


  • Abbott Laboratories
  • Ambisea Technology
  • B. Braun Melsungen AG
  • Htl-Strefa S.A
  • Johnson & Johnson
  • Novo Nordisk
  • MORE
1. Report Focus
A. Introduction
- Diabetes Know-How
- Diabetes Administration Concerns
- Typical Practices
- Vital Pointers
- Type 1 Diabetics
- Type 2 Diabetes
- Insulin Types
- Insulin Delivery - Preface
- Insulin Pens
- Insulin Pen Needles
- Benefits And Drawbacks Of Insulin Pens
- Insulin Syringes
- Dimensions Of Insulin Syringes
- Standard U-100 Insulin Syringes
- Benefits And Drawbacks Of Insulin Syringes
- Positives
- Negatives
- Insulin Pumps
- Insulin Pumps And Insulin Pump Therapy
- External Insulin Pumps
- Embedded Insulin Pumps
- Patch Pumps
- Benefits And Drawbacks Of Insulin Pumps
- Positives
- Negatives
- Insulin Injection Supports
- Insulin Jet Injectors
- Benefits And Drawbacks Of Insulin Jet Injector
- Positives
- Negatives
- Insulin Inhalers
- Benefits And Drawbacks Of Inhalable Insulin
- Positives
- Negatives
- Infusion Sets
- Diabetes Software
- Wallets & Carry Cases
- Insulin Pills
- Nasal Spray
- Benefits Of Insulin Pens Over Conventional Syringes
- J. Invasive Insulin Delivery Devices - Geography Market Briefing
- The Americas
- Europe
- Asia-Pacific
- Africa
- Middle East

2. Market Analysis
- Insulin Delivery Devices - Industry Snapshot
A. Insulin Delivery Devices - Segmentation
- Insulin Delivery Devices - Global
- Insulin Delivery Devices - By Segments
- Invasive Insulin Delivery Devices - Global
- Invasive Insulin Delivery Devices - By Geography
- The Americas
- Europe
- Asia-Pacific
- Africa
- Middle East
- Insulin Delivery Devices - By Invasive Devices Type
- Invasive Insulin Delivery Devices - Type - By Geography
- Insulin Syringes
- The Americas
- Europe
- Asia-Pacific
- Africa
- Middle East
- Insulin Pens
- The Americas
- Europe
- Asia-Pacific
- Africa
- Middle East
- Invasive Insulin Delivery Devices - Insulin Pens - By Type
- Insulin Pumps
- The Americas
- Europe
- Asia-Pacific
- Africa
- Middle East
- Other Invasive Insulin Delivery Devices
- The Americas
- Europe
- Asia-Pacific
- Africa
- Middle East
B. Growth Rate Analysis
- Global Insulin Delivery Devices - Segment Growth Rates
- Invasive Insulin Delivery Devices
- Invasive Insulin Delivery Devices Market - Type
- Global Invasive Insulin Delivery Devices - Type Growth Rates
- Insulin Pens Market - Type
- Global Insulin Pens - Type - Growth Rates
C. Investment Focus

3. Industry Overview
A. Diabetes Prevalence Worldwide According To World Health Organization (Who)
- Diabetes Is On The Rise Globally
- Industry
- Diabetes - A Worldwide Perspective
- Diabetes Business Worldwide
- Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Taiwan
- Countries With High Diabetes Prevalence
B. Market Trends
- Infusion Pump Improvement Initiative
- Animas® Vibe®
- Insulet Announces Development Partner For The Omnipod Artificial Pancreas Company's Alliance With Algorithm Partner Marks Critical Step Forward In Advanced Diabetes Treatment
- Insulet Deals Neighborhood Diabetes Biz To Liberty Med For $5M
- The Omnipod™ Insulin Management System, The World’S First Tubeless Insulin Pump, Is Now Available For Canadians With Type 1 Diabetes
- Partnering To Deliver Integrated Care For Better Patient Outcome
- Innovative New Insulin Pumps (Existing & Under Development)
- Launch Of The Abcd Insulin Pump Network Uk
- Quick-Set® Infusion Set
- Minimed Paradigm Revel™ Insulin Pump
- Accu-Chek® And Bluetooth® Technologies Allow You To Remotely Control Your Pump, Making Insulin Delivery Easy, Quick And Discreet.
- Calibra Finesse Bolus Insulin Patch Pump To Launch In The Us In 2016
- Insulin Patch Pumps
- Development Of A New Measure For Assessing Insulin Delivery Device Satisfaction In Patients With Type 1 And Type 2 Diabetes
- Novo Knocks It Out Of The Park With New "Echo" Smart Insulin Pen
- Fda Approves New Insulin Pump-Continuous Sensor Combo
- Evolving Trends In Insulin Delivery: In Pursuit Of Improvements In Diabetes Management
- Various Emerging Trends In Insulin Drug Delivery Systems
- Insulin Pens: Improving Adherence And Reducing Costs
- Insulin Pumps
- Inhaled Insulin
- Barriers To Conventional Insulin Injection Therapy
- Newer Insulin Delivery Methods
C. Key Company Profiles

4. Industry Company Database
- Insulin Delivery Device Companies
- Diabetes Care Companies

5. Appendix
A. Research Focus
B. About
C. Disclaimer
D. Feedback
Note: Product cover images may vary from those shown
3 of 5


4 of 5
- Abbott Laboratories
- Allison Medical, Inc.
- Ambisea Technology
- Animas Corp.
- B. Braun Melsungen AG
- Becton, Dickinson And Company
- Eli Lily And Company
- F. Hoffmann-La Roche, Ltd.
- Htl-Strefa S.A
- Insulet Corporation
- Johnson & Johnson
- Medtronic, Inc.
- Novo Nordisk
- Owen Mumford, Ltd.
- Sanofi-Aventis
- Sooil Development
- Tandem Diabetes Care, Inc.
- Terumo Corporation
- Ultimed, Inc.
- Valeritas
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown